Page 429 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

Index 403

conductive hearing loss, 180 CSS, 17, 215, 373
conference, 52, 72, 107, 121, 122, 141, 152, 189, CT, 18, 19, 22, 45, 46, 149, 150, 167, 209, 210, 242,

257, 291, 358, 359 243, 244, 246, 247, 248, 249, 251, 252, 254, 255,
confounders, 157 257, 268, 284, 291, 317, 322, 326, 328, 335, 339,
congestive heart failure, 301 347, 349, 359
conjunctiva, 345, 346 CT scan, 22, 243, 244, 247, 349
conjunctivitis, 72, 147, 179, 344, 345, 347, 348, 349, CTA, 18, 20, 41, 43, 45, 167, 281, 316, 320
culture, 45
350, 351, 352, 356 cure, 139, 213, 218, 271
connective tissue, 17, 21, 23, 29, 44, 49, 156, 166, CV, 17, 29, 47, 48, 125, 132, 134, 135, 136, 140,
227, 228, 229, 230, 231, 232, 233, 234, 235, 236,
169, 173, 258, 278, 290, 296, 307, 373 237, 238, 248, 252, 290, 338, 352, 353, 373, 379,
consciousness, 34 380, 386, 392
consolidation, 244, 246, 248, 250, 252, 257 CXC, 195
constituents, 126, 193, 376 cyclosporine, 305, 334
constrictive pericarditis, 249 cyst, 30
consumption, 87, 163, 232 cystitis, 48, 170, 217
contour, 387 cystoid macular edema, 354, 355
control group, 48 cytokines, 43, 75, 97, 98, 99, 100, 106, 118, 184,
controlled studies, 238, 349 265, 314, 381, 388
controlled trials, 324 cytology, 45
controversial, vii, 76, 100, 104, 157, 266 cytomegalovirus, 163, 177, 187, 245, 290, 296, 386
controversies, 154, 328, 332 cytometry, 156
convulsion, 25 cytoplasm, 52, 70, 86, 94, 115, 159, 177, 178, 191,
COPD, 351 193, 194, 241, 242, 246, 259, 343
cornea, 354 cytotoxic agents, 44, 214, 217, 218
corneal ulcer, 348 cytotoxic immunosuppressive agent, 32, 304
coronary arteries, 5, 129, 147, 166, 209, 222, 303 cytotoxicity, 53, 195, 220, 269
coronary artery aneurysms, 114, 286
coronary artery disease, 147, 148 D
coronary artery spasm, 222
correlation(s), 6, 31, 57, 111, 193, 220, 233, 255, dacryoadenitis, 349
DALY, x
275, 292, 303, 342, 365, 369, 370, 395, 397 database, 25, 26, 101, 150, 202, 214, 289, 293, 300,
cortex, 34, 40
corticosteroid therapy, 28, 32, 33, 46, 56, 168, 222, 362
deaths, 212, 215
294, 330, 341 debridement, 305
cost, 156, 169, 270, 319, 321 defects, 166, 172, 186
cost effectiveness, 321 deficiency(s), 17, 76, 86, 88, 115, 163, 191, 192,
cost saving, 156
cotton, 344, 351, 353, 354, 355, 367 196, 351
cough, 23, 180, 232, 249, 251, 380 deficit, 40, 150, 341, 357
covering, 69, 71, 154 degradation, 94
cranial nerve, 23, 26, 34, 44, 206, 256, 316 dehiscence, 127, 129, 184
craniotomy, 37 dehydration, 201
creatine, 45 delirium, 33, 35
creatinine, 49, 148, 179, 201, 216, 268, 283, 285, dementia, 30, 35, 39, 59
demyelination, 303
289, 380, 392 dendritic cell, 313
crescentic glomerulonephritis, 52, 87, 88, 90, 93, Denmark, 70, 72, 73, 81, 82, 171, 360
deposition, 25, 54, 87, 88, 92, 134, 147, 163, 188,
134, 154, 182, 183, 184, 188, 198, 266, 268, 272,
273, 274, 350 198, 202, 227, 229, 286, 353, 372, 374, 375, 376,
crops, 25, 266 380, 381
cross-sectional study, 307, 317, 360
CRP, 162, 282, 318, 325, 342, 381
crystalline, 264, 272
CSF, 36, 37, 38, 39, 41, 56, 59, 206

Complimentary Contributor Copy